The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
about
ATP-dependent chromatin remodeling complexes as novel targets for cancer therapyGenome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysisDietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cellsEffect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromastsTranscription factor AP-2γ is a core regulator of tight junction biogenesis and cavity formation during mouse early embryogenesis.Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesisPlant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cellsHistones: Controlling Tumor Signaling CircuitryFormulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression.Suberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction networkCrucial function of histone deacetylase 1 for differentiation of teratomas in mice and humansZyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cellsEndogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy.Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress.Class I histone deacetylase activity is required for proliferation of renal epithelial cells.HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation.Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice.Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors.SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.Modulation of cell cycle regulators by HDACs.Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2.Histone deacetylases in neural stem cells and induced pluripotent stem cells.Multiple roles of class I HDACs in proliferation, differentiation, and development.Transcription and beyond: the role of mammalian class I lysine deacetylasesClass I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy.Structure and function insights into the NuRD chromatin remodeling complex.Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis.Toxoplasma gondii Rhoptry Protein ROP16 Mediates Partially SH-SY5Y Cells Apoptosis and Cell Cycle Arrest by Directing Ser15/37 Phosphorylation of p53Loss of histone deacetylase Hdac1 disrupts metabolic processes in intestinal epithelial cells.LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cellsHistone deacetylases 1 and 2 act in concert to promote the G1-to-S progression.Chemical and structural biology of protein lysine deacetylases
P2860
Q26849467-9A2528A7-A715-4EDF-A817-7459BB865FEFQ28237462-8C44BB6C-BC20-42B0-A3FC-C8F8E326143FQ28257534-E52F6252-8D4E-4DB3-B7AF-4E014E192782Q30424521-A0B71627-78F3-4D88-8841-01C0587A9AE8Q30529634-C4D17084-2B20-4A5D-A82B-B0AA7065FF77Q33390343-E43E0C43-EAA5-4B66-9BB0-9E9719056F71Q33606387-91BD72D7-63DB-40E5-A855-5184DDE6B71DQ33845099-4FD9C950-A261-4BA7-91CB-53ABF68452B7Q33913080-677C9F3A-EA17-488C-ACFD-7D8278579E56Q33919809-415DA094-007F-4FD5-BF96-90B713981CFDQ34109472-80AC000C-E1C2-421B-9BB9-71FC95BCCDCAQ34323964-1067467D-5363-4732-847D-255AB5FC0CFBQ34468386-D357D5AB-2D50-44B8-9A5A-E07A94FA5948Q34488391-0F944A8F-D360-42BF-BB32-F7ACE0CB87A7Q35098895-75587876-9837-41CA-8696-4C9661AB1500Q35975127-6A837BCF-034B-4FC1-A228-2925B44456B7Q36070032-1535B020-4DCA-4F78-9257-829C68037734Q36346870-DB193682-334E-4E8A-8BED-37B8852993F0Q37093664-1ED51ACB-21DE-4D72-84C4-CA26D46ED8E8Q37098834-E16C7E8E-A78B-40FD-A3FF-A70AE0AF2452Q37331641-890D7AB9-EBAF-49A1-B1C0-6F9B99E3B221Q37416288-4177B76B-3E6B-430E-9F85-4A66EFED37F5Q37589239-32DF3704-0239-4625-8EFB-262D05FE6975Q37698902-9F43CFDC-8633-411A-966C-84807AE4D4BDQ37706886-5FDDFD66-34B9-4BDC-8B97-BF5532738549Q37708543-53D978BD-D3F6-423C-AC19-C6F47110B6DBQ37825437-8D4758D7-366B-47E7-A93F-E2D8F6227CFAQ37918348-38B19682-F519-4DA4-8CC2-1D29F0467F34Q37979639-DC8A2AC0-1B9A-4ACB-AAB9-6EF4234D370FQ38156341-AC991E15-B9BB-4DB0-B3ED-7F0AB8307B15Q38204487-720389E2-9AB3-4B1D-A9FF-EE79D6992DA5Q38386331-7B11F941-0C47-494F-9DB3-8C8953708C38Q38677842-CAE79B51-B11B-446D-9142-1568DD2B910FQ38838992-8B2587D4-93FD-4F34-8F54-FBACADD6757DQ38841768-34EBC382-58CD-4A99-8BA9-4A9EEC1DFA47Q38936732-31184427-35E2-4AF3-A86B-B6314DAA98B0Q38947405-3C462610-24A7-46C4-8E5E-3D9BE1982470Q39038132-48C8ED05-93B6-458F-90F5-C3BD547976B1Q39247455-2A53BFF3-1D83-48A4-8BA1-CC7128A1210AQ39299912-9FF5B1E7-CF11-4C98-BC51-74C312B2BB80
P2860
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@ast
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@en
type
label
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@ast
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@en
prefLabel
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@ast
The cyclin-dependent kinase in ...... tor of cellular proliferation.
@en
P2093
P2860
P50
P356
P1476
The cyclin-dependent kinase in ...... ator of cellular proliferation
@en
P2093
Dominique Meunier
Fritz Propst
Jennifer Jurkin
Julia Tischler
Martina Rembold
Reinhard Brunmeir
Reinhard Grausenburger
Silvia Senese
Susanna Chiocca
P2860
P304
P356
10.1128/MCB.01500-09
P407
P577
2009-12-22T00:00:00Z